Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 16,117 |
|
|||||
| News | - | ||||||
| Day High | 12.00 | Low High |
|||||
| Day Low | 11.90 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Oculis Holding AG | OCS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 11.90 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 11.90 | 11.90 | 12.00 | 11.90 | 11.90 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 82 | 16,117 | US$ 11.91 | US$ 192,007 | - | 9.05 - 14.50 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 14 | US$ 11.98 | USD |
Oculis Holding AG Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 436.13M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Oculis News
Real-Time news about Oculis Holding AG (NASDAQ): 0 recent articles
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OCS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.10 | 12.10 | 11.86 | 11.97 | 9,034 | -0.20 | -1.65% |
| 1 Month | 12.01 | 13.30 | 11.85 | 12.37 | 41,258 | -0.11 | -0.92% |
| 3 Months | 12.94 | 13.30 | 10.55 | 11.95 | 41,415 | -1.04 | -8.04% |
| 6 Months | 9.97 | 14.465 | 9.60 | 11.93 | 39,967 | 1.93 | 19.36% |
| 1 Year | 12.80 | 14.50 | 9.05 | 11.88 | 29,842 | -0.90 | -7.03% |
| 3 Years | 10.95 | 14.50 | 6.26 | 11.47 | 28,600 | 0.95 | 8.68% |
| 5 Years | 10.95 | 14.50 | 6.26 | 11.47 | 28,600 | 0.95 | 8.68% |
Oculis Description
| Oculis Holding AG is a Switzerland-based company primally engaged in biotechnology sector. The Company is focused on the development of eye disease treatment for ophthalmology. It includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide. |
